标题
Inflammation in Atherosclerosis—No Longer a Theory
作者
关键词
-
出版物
CLINICAL CHEMISTRY
Volume 67, Issue 1, Pages 131-142
出版商
Oxford University Press (OUP)
发表日期
2020-11-06
DOI
10.1093/clinchem/hvaa275
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Vaccination Strategies and Immune Modulation of Atherosclerosis
- (2020) Jan Nilsson et al. CIRCULATION RESEARCH
- Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas
- (2020) Alma Zernecke et al. CIRCULATION RESEARCH
- Role of the adaptive immune system in atherosclerosis
- (2020) Klaus Ley BIOCHEMICAL SOCIETY TRANSACTIONS
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atherosclerotic Plaque Healing
- (2020) Rocco Vergallo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemokines as Therapeutic Targets in Cardiovascular Disease
- (2019) Heidi Noels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Novel Antiatherosclerotic Therapies
- (2019) Peter Libby et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Targeting the Immune System in Atherosclerosis
- (2019) Tian X. Zhao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clonal Hematopoiesis
- (2019) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk
- (2019) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- From Focal Lipid Storage to Systemic Inflammation
- (2019) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
- (2019) Siddhartha Jaiswal et al. Nature Reviews Cardiology
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- The role of B cells in atherosclerosis
- (2018) Andrew P. Sage et al. Nature Reviews Cardiology
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin
- (2016) Paul M Ridker EUROPEAN HEART JOURNAL
- A Test in Context
- (2016) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- In celebration of the 100th anniversary of the lipid hypothesis of atherosclerosis
- (2013) Daniel Steinberg JOURNAL OF LIPID RESEARCH
- A Randomized Trial of Colchicine for Acute Pericarditis
- (2013) Massimo Imazio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Clinical implications of inflammation for cardiovascular primary prevention
- (2010) P. Libby et al. EUROPEAN HEART JOURNAL
- The Discovery of Cellular Immunity in the Atherosclerotic Plaque
- (2009) Göran K. Hansson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
- (2009) Paul Elliott JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started